NCT06345833View on ClinicalTrials.gov

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
HemophiliaHemorrhageFacelift Surgery
Interventions
DRUG

1%Tranexamic acid with standard local

1% TXA mixed with standard local consisting 1/4% lidocaine with 1:100,000 epinephrine with saline as the control.

DRUG

3% TXA

3% TXA on TXA-soaked pledgets applied for 10 minutes with saline as the control.

DRUG

1% TXA with local plus 3% TXA-soaked pledgets

1% TXA with local plus 3% TXA-soaked pledgets with saline as the control.

Trial Locations (1)

55414

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER